PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Phase I Clinical Trial Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.\', \'Sinocelltech Ltd., Beijing, China.\', \'Beijing Engineering Research Center of Protein and Antibody, Beijing, China.\', \'Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/AAC.01063-21
?:hasPublicationType
?:journal
  • Antimicrobial agents and chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34491805
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.291
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34491805>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34491805>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all